Leptin Receptor Signaling and Action in the Central Nervous System by Leshan, Rebecca L. et al.
Leptin Receptor Signaling and Action in the
Central Nervous System
Rebecca L. Leshan, Marie Björnholm, Heike Münzberg, and Martin G. Myers, Jr
Abstract
LESHAN, REBECCA L., MARIE BJÖRNHOLM, HEIKE
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The increasing incidence of obesity in developed nations
represents an ever-growing challenge to health care by
promoting diabetes and other diseases. The discovery of the
hormone, leptin, a decade ago has facilitated the acquisition
of new knowledge regarding the regulation of energy bal-
ance. A great deal remains to be discovered regarding the
molecular and anatomic actions of leptin, however. Here,
we discuss the mechanisms by which leptin activates intra-
cellular signals, the roles that these signals play in leptin
action in vivo, and sites of leptin action in vivo. Using
“reporter” mice, in which LRb-expressing (long form of the
leptin receptor) neurons express the histological marker,
-galactosidase, coupled with the detection of LRb-medi-
ated signal transducer and activator of transcription 3 sig-
naling events, we identified LRb expression in neuronal
populations both within and outside the hypothalamus. Un-
derstanding the regulation and physiological function of
these myriad sites of central leptin action will be a crucial
next step in the quest to understand mechanisms of leptin
action and energy balance.
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Introduction
Leptin is produced in proportion to fat stores; adequate
leptin levels serve to communicate the repletion of body
energy stores to the central nervous system (CNS)1 to
suppress food intake and permit energy expenditure (1–3).
Conversely, lack of leptin signaling caused by mutation of
leptin (e.g., ob/ob mice) or the leptin receptor (LR; e.g.,
db/db mice) in rodents and humans results in increased food
intake in combination with a phenotype of reduced energy
expenditure reminiscent of the neuroendocrine starvation
response (1,2,4). Leptin also regulates insulin sensitivity
and glucose homeostasis by two mechanisms: one by con-
trolling energy balance and body fat (increased body adi-
posity leads to insulin resistance) and the other through an
adiposity-independent pathway mediated by the CNS (5,6).
LR Signaling
The long form of the LR, LRb, mediates intracellular
signaling and is, thus, crucial for leptin action (3,7,8). LRb
initiates signals by activating a non-covalently associated
Jak family tyrosine kinase (JAK2) that autophosphorylates
on numerous tyrosine residues as well as phosphorylating
tyrosine residues on LRb during leptin stimulation (8–10).
The phosphorylation of tyrosine at position 985 (Tyr985) on
LRb recruits the tyrosine phosphatase, tyrosine phosphatase
2, which thereby mediates a portion of the activation of the
canonical p21ras3 extracellular signal-regulated kinase
(ERK) signaling pathway in cultured LRb-expressing cells.
Tyr985 also plays an important role in LRb signal attenua-
tion by binding the inhibitory suppressor of cytokine sig-
naling-3 (SOCS3) molecule (11).
Phosphorylation of Tyr1138 recruits the latent transcrip-
tion factor, signal transducer and activator of transcription 3
(STAT3), to the LRb/JAK2 complex, resulting in the ty-
rosine phosphorylation and nuclear translocation of STAT3
to effect its regulation of transcription (9,10). Among other
genes, STAT3 activates the transcription of the neuropep-
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tide, proopiomelanocortin (POMC), and the signaling inhib-
itor, SOCS3 (10,12,13). Tyr1077 and Tyr1138 on LRb coop-
erate to mediate activation of STAT5. JAK2 tyrosine
phosphorylation during LRb stimulation mediates some sig-
nals independently of tyrosine phosphorylation sites on LRb
(e.g., a portion of ERK activation), but the exact nature and
function of these signals is not yet fully understood (10).
LRb Signaling in the Regulation of
Physiology
Roles for a number of intracellular signaling pathways
have been examined in the regulation of energy balance.
The pharmacological inhibition of phosphatidylinositol
3-kinase (PI3K) blocks the suppression of feeding by leptin,
suggesting that PI3K signaling contributes to the regulation
of energy balance by leptin (14). Indeed, activation of the
PI3K-regulated Akt/protein kinase B pathway in the hypo-
thalamus mediates anorexia (15). Although the deletion of
SHP-2 or STAT3 from forebrain neurons results in over-
feeding and obesity (16,17), it is not clear whether this
obesity stems from perturbations in leptin signaling, per se,
or is the less-specific consequence of the widespread dele-
tion of these promiscuous signaling molecules. The role of
LRb3STAT3 signaling in energy balance has been clearly
established by the study of rodents containing a homolo-
gous replacement of LRb by a receptor mutant for Tyr1138,
the STAT3 binding site (13,18,19), however. The LRb
Tyr11383 STAT3 signal is required for the control of feed-
ing and energy expenditure by leptin, although this signal is
not absolutely required for the regulation of growth, repro-
duction, immune function, and glycemic control. Thus, an-
other signaling pathway must mediate these STAT3-inde-
pendent functions of LRb.
Leptin Action in the CNS
Many of the actions of leptin are attributable to effects in
the CNS, particularly in the basomedial hypothalamus, in-
cluding the arcuate nucleus (ARH) (2,20). Thus, LRb sig-
naling stimulates the elaboration of anorectic neuropeptides
and suppresses the action of orexigenic peptides in the
ARH. The finding that the ARH-specific expression of LRb
action ameliorates appetite and decreases adiposity in ro-
dents lacking LRb suggests the importance of ARH leptin
action for energy balance (21,22). An important component
of the adiposity-independent regulation of glucose metabo-
lism by leptin is also mediated through the ARH (22). It is
clear, however, that ARH leptin action represents only one
component of leptin action on energy balance, because the
deletion of LRb from POMC neurons results in a relatively
modest overweight phenotype, and the restoration of LRb
expression specifically in the arcuate nucleus of db/db mice
reverses only a portion of the hyperphagia and obesity of
these animals (22,23). Other populations of leptin-respon-
sive (i.e., LRb-expressing) neurons within the hypothala-
mus and elsewhere in the CNS remain uncharacterized.
Genetic Reporter System for LRb Expression
and Action in the CNS
While several assays detect LRb expression within the
CNS, each of these has limitations that prompted us to
seek a more facile system for identifying LRb-expressing
neurons. In situ hybridization histochemistry (ISH) for LRb
is difficult, more so if done in combination with immuno-
histochemistry (IHC) or immunofluorescence (IF) for other
proteins. Furthermore, the detection of leptin-induced
STAT3 phosphorylation by IHC/IF or of leptin-induced
SOCS3 expression by ISH, while robust, requires prior
treatment with leptin, limiting the use of this method for
functional assays in the absence of leptin or LRb. We
generated mice in which an internal ribosome entry site
plus the coding sequence for the cre recombinase were
genetically targeted into the 3-non-coding region of the
LRb-specific exon within the leptin receptor gene (leprCre
Figure 1: LeprCre; i-gal reporter mice. (A) We used genetic
targeting in mouse embryonic stem cells (ES cells) to insert an
IRES element plus the coding sequences for cre recombinase into
the 3-untranslated region of exon 18b, the LRb exon, placing cre
expression under the control of the mRNA encoding LRb. Cor-
rectly targeted ES cells were used to generate mice expressing cre
in LRb-expressing cells (leprCre mice). To produce experimental
animals, we mated LRb-cre mice with ROSA26-i-gal or actin-
i-gal (B) mice, in which a floxed transcription blocker precedes
lacZ, such that -galactosidase expression is only permitted after
Cre-mediated recombination/removal of the transcription blocker.
In the ROSA26-i-gal strain, expression is driven by the ROSA26
promoter. In actin-i-gal mice, expression is driven by the chicken
-actin promoter. In LeprCre; i-gal mice, cre-mediated excision
of the transcription blocker results in -gal expression in cells
expressing LRb and in which the transgene promoter is active.
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mice; Figure 1A). The LRb coding region of these mice is
fully intact, suggesting that energy homeostasis in these
animals should be normal; indeed, we have not observed
any body weight phenotype in animals homozygous for
leprCre compared with control animals. We crossed these
leprCre animals with mice containing transgenes encoding
cre-inducible -galactosidase expression (i-gal), wherein
cre recombinase expression removes a transcription-block-
ing cassette that is flanked by LoxP sites, enabling the
expression of downstream -gal coding sequences (Figure
1B). We used two strains of i-gal mice, ROSA26-i-gal
(24) and actin-i-gal (25), in which the promoters for
ROSA26 and chicken -actin drive transgene expression,
respectively. Thus, in the leprCre; i-gal mice, we expect
excision of the transcription blocker and subsequent -gal
expression in neurons that express high levels of LRb
mRNA and in which the promoter for the i-gal transgene
operates strongly (Figure 1B).
The immunofluorescent detection of -gal in the brains
of the leprCre; i-gal mice revealed positive cells in the
ARH and ventromedial hypothalamus (VMH) in both re-
porter strains. Specific to the actin-i-gal mice, we observed
abundant -gal–expressing cells in the hippocampus (data
not shown), as well as smaller numbers of cells in the pons
and VMH. In ROSA26-i-gal reporter animals, positive
cells were abundant in the ARH, premammillary nucleus,
dorsomedial hypothalamus, lateral hypothalamus, VMH,
and dorsal raphe. No -gal expression was detected in either
i-gal strain in the absence of the leprCre allele. The distri-
bution of positive cells in both reporter strains is summa-
rized in Table 1. The distribution of -gal in these reporter
animals is consistent with the previous detection of LRb
mRNA and with a potential functional role for leptin action
in these regions (26).
To validate the expression of functional LRb in these
-gal–positive neurons, we performed double-label IF to
detect both -gal and pSTAT3 in leptin- or phosphate-
buffered saline–treated leprCre; ROSA26-i-gal reporter
mice (Figure 2). We observed cells positive for both
pSTAT3 and -gal in the ARH, premammillary nucleus,
dorsomedial hypothalamus, VMH, lateral hypothalamus,
and dorsal raphe. While not all neurons with leptin-induced
pSTAT3 were labeled by -gal expression, almost all
cells expressing -gal were also positive for pSTAT3. Thus,
whereas populations of LRb neurons exist that are not
labeled by this genetic method, the -gal–positive neurons
Table 1. Sites of observed -gal immunoreactivity in reporter mouse brains. Relative densities of -gal
immunoreactive cells in leprCre; ROSA26-i-gal and leprCre; and Actin-i-gal
ROSA26 Actin Functions of the Region
FOREBRAIN
Hippocampus Learning; memory





arcuate nucleus  Feeding; Energy homeostasis
ventromedial hypothalamus   Satiety
dorsomedial hypothalamus   Feeding; Energy homeostasis; Reproduction
lateral hypothalamus   Hunger, reward, attention
premammillary nucleus, ventral part   Reproduction; Anxiety; Fear conditioning
MIDBRAIN
dorsal raphe   Cognition; Arousal; Stress response; Feeding
HINDBRAIN
Pons
reticulotegmental nucleus of the pons   Occulomotor circuit component; Arousal
rostral periolivary region   Auditory functions?
Medulla
nucleus of the solitary tract   Energy homeostasis; Cardiorespiratory responses
, high; , medium; , low; , none above background.
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in these reporter mice express functional LRb and respond
to leptin.
This method for identifying LRb-expressing neurons
should facilitate the dissection of the regulation and func-
tion of LRb-expressing populations of neurons throughout
the brain. Understanding the biology of these novel popu-
lations of leptin-responsive neurons will be crucial for our
understanding of the mechanisms regulating energy balance
and in designing future therapies for obesity.
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